Clinical Trials Logo

Disabilities Multiple clinical trials

View clinical trials related to Disabilities Multiple.

Filter by:

NCT ID: NCT04999085 Completed - Multiple Myeloma Clinical Trials

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

Myeloma is the second most common type of blood cancer in the United States. Myeloma most commonly affects older adults. While some younger individuals do get myeloma, the average age when people are first diagnosed with myeloma is around 69 to 70. Along with having a higher risk for myeloma, older adults have an increased chance of developing other health problems or issues. However, not everyone ages in the same way. Some older adults experience major changes in health or degree of independence at relatively younger ages, while others remain quite healthy for many years. The specific issues that develop with age can also vary from person to person. One older adult may face difficulties with vision or hearing, while another may develop memory problems. Historically, cancer doctors have not done a very good job identifying these non-cancer issues. As a result, research has focused on better ways to systematically pick up on issues that may impact cancer outcomes or quality of life. The outgrowth of this research is assessments and questionnaires referred to as "comprehensive geriatric assessments," which evaluate the health and functionality of older adults thoroughly but efficiently. In both myeloma and other types of cancer, problems identified through geriatric assessments have been shown to predict how likely people are to develop side effects of cancer treatment and predict how long people are likely to live with cancer. Prior research has not addressed how best to help with the issues picked up through a geriatric assessment among patients undergoing treatment for myeloma, although a number of effective interventions have been shown to benefit older adults with similar problems in other settings. Therefore, the current study will test a strategy of systematically screening older adults undergoing myeloma treatment for geriatric-assessment-related deficits and referring participants to appropriate services and resources. The geriatric assessment in this study includes tests of mobility, memory, vision, hearing, and nutrition as well as questions about symptoms and social support. Individuals who have deficits in one of these areas will be referred to relevant services and resources such as physical therapy, a pharmacist, or the cancer center support program. They will then repeat the same assessment three months later, and the results will be compared to their original assessment to see if the deficit has improved, with particular attention to mobility and social support.

NCT ID: NCT04525742 Completed - COVID-19 Clinical Trials

COVID-19 Pandemic and Parents of Disabled Children

Start date: July 5, 2020
Phase: N/A
Study type: Interventional

Pandemic period could affect the disabled children's rehabilitation and follow-up negatively because of preventive measures and this could create adverse results on their parents. In this research, it is aimed to determine the positive and negative effects of pandemic on parents and disabled children and to provide an insight for future solutions.

NCT ID: NCT04498637 Completed - Disability Physical Clinical Trials

Attitudes Towards Disability of Nursing and Physiotherapy Students

Start date: September 1, 2017
Phase:
Study type: Observational

The general objective of this study is to know the attitude towards people with disability of Nursing and Physiotherapy students in the University of Cadiz. This is a descriptive, correlational, transversal and synchronous study.

NCT ID: NCT04485312 Completed - Clinical trials for Disabilities Multiple

Chance to Avoid New Caries by Adding Chlorhexidine to the Preventive Protocol in Adolescent Special Needs

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

Adolescent Special need individuals are most need of easy forms of antibacterial agents, so in this study, using chemotherapeutic agents like the newly introduced varnish containing chlorhexidine seems to be a quite promising tool for local delivery to patients with special needs . Chlorhexidine is a wide spectrum very effective bactericidal used for years against the oral flora while fluorides are well known with their antibacterial ability. This may be an excellent way to reduce the risk assessment in adolescent special needs patients.

NCT ID: NCT03769480 Enrolling by invitation - Clinical trials for Disabilities Multiple

Investigation of the Relationship Between Pulmonary Function and Muscle Strength in Athletes With Disability

Start date: November 1, 2018
Phase:
Study type: Observational [Patient Registry]

To investigate the relationship between respiratory function and core muscles strength in athletes with disabilities and compare with healthy athletes.

NCT ID: NCT03226912 Completed - Depression Clinical Trials

The PREDICT Study- a Registry in Critically Ill Patients to Determine Predictors of Disability Free Survival

PREDICT
Start date: July 18, 2017
Phase:
Study type: Observational

As mortality from critical illness has reduced, the importance of measuring disabilities (cognitive, functional and psychological) in surviving critically ill patients has become more important. Currently, the causes, long-term effects and frequency of disabilities in patients surviving ICU in Australia are unknown. In the US and UK, studies have been undertaken to assess the effects of specific long-term outcomes, such as functional disability and depression, which found long-term disabilities were much higher than baselines (pre-illness function) and ongoing at five years after ICU discharge. In order to improve quality of life of ICU survivors and ensure that medical specialists apply appropriate interventions to reduce the cost of these surviving patients on the community, the PREDICT management committee proposes the introduction of a patient-reported outcomes registry.